Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/115004
| DC Field | Value | Language |
|---|---|---|
| dc.contributor | Department of Rehabilitation Sciences | - |
| dc.creator | Zhao, J | - |
| dc.creator | Wang, YM | - |
| dc.creator | Huang, WD | - |
| dc.creator | Xu, RH | - |
| dc.creator | Yang, XM | - |
| dc.creator | Wang, P | - |
| dc.date.accessioned | 2025-09-02T00:32:03Z | - |
| dc.date.available | 2025-09-02T00:32:03Z | - |
| dc.identifier.issn | 1471-2407 | - |
| dc.identifier.uri | http://hdl.handle.net/10397/115004 | - |
| dc.language.iso | en | en_US |
| dc.publisher | BioMed Central | en_US |
| dc.rights | Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. | en_US |
| dc.rights | The following publication Zhao, J., Wang, Y., Huang, W. et al. Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients. BMC Cancer 25, 421 (2025) is available at https://dx.doi.org/10.1186/s12885-025-13624-z. | en_US |
| dc.subject | QLQ-C30 | en_US |
| dc.subject | Health-related quality of life | en_US |
| dc.subject | Community cancer patients | en_US |
| dc.subject | Prediction | en_US |
| dc.subject | Mortality | en_US |
| dc.title | Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients | en_US |
| dc.type | Journal/Magazine Article | en_US |
| dc.identifier.volume | 25 | - |
| dc.identifier.doi | 10.1186/s12885-025-13624-z | - |
| dcterms.abstract | Background To evaluate the ability of QLQ-C30 in predicting mortality in community-based cancer patients in China. | - |
| dcterms.abstract | Methods A whole-cluster sampling method was adopted to enroll cancer patients in four communities in Shanghai from 2018 to 2019. The patients were surveyed using a questionnaire enquiring demographic information, cancer types, and QLQ-C30 scale. Death information of participants was collected and updated from community health care centers. Cox regression models were used to assess the relationship between various QLQ-C30 scores (i.e., total score, five dimension scores, and utility score) and all-cause mortality. | - |
| dcterms.abstract | Results A total of 3,304 participants were enrolled with a mean age of 63.9 years. Among them, 2,710 patients survived while 594 died by 2023. The mean total QLQ-C30 score in living patients was statistically significantly higher than that in deceased patients ( 92.96 vs. 85.21, p < 0.001); and the mean values of the five dimension scores and utility score were also significantly higher for the living patients. Cox regression models with the adjustment of covariates also confirmed that higher QLQ-C30 scores were associated with lower risk of death, with the hazard ratio value being 0.81 for the total score, 0.83-0.89 for the dimension scores, and 0.83 for the utility score, respectively (p < 0.001 for all). | - |
| dcterms.abstract | Conclusions QLQ-C30 could accurately predict all-cause mortality in Chinese community cancer patients. | - |
| dcterms.accessRights | open access | en_US |
| dcterms.bibliographicCitation | BMC cancer, 2025, v. 25, 421 | - |
| dcterms.isPartOf | BMC cancer | - |
| dcterms.issued | 2025 | - |
| dc.identifier.isi | WOS:001439803800009 | - |
| dc.identifier.artn | 421 | - |
| dc.description.validate | 202509 bcrc | - |
| dc.description.oa | Version of Record | en_US |
| dc.identifier.FolderNumber | OA_Scopus/WOS | en_US |
| dc.description.fundingSource | Others | en_US |
| dc.description.fundingText | National Natural Science Foundation of China | en_US |
| dc.description.pubStatus | Published | en_US |
| dc.description.oaCategory | CC | en_US |
| Appears in Collections: | Journal/Magazine Article | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| s12885-025-13624-z.pdf | 1.08 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.



